Lantheus Holdings Inc (FRA:0L8) Stock Price, Trades & News

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Financial Strength

7/10

Name	Current	Vs Industry
Cash-To-Debt	0.95
Equity-to-Asset	0.54
Debt-to-Equity	0.48
Debt-to-EBITDA	1.33
Interest Coverage	15.26
Piotroski F-Score	5/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	5.58	Distress Grey Safe
Beneish M-Score	-2.65	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

7/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	19.4
	3-Year EBITDA Growth Rate	72
	3-Year EPS without NRI Growth Rate	12.9
	3-Year FCF Growth Rate	11
	3-Year Book Growth Rate	36.6
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	6.98
	Future 3-5Y Total Revenue Growth Rate Estimate	6.94

Momentum Rank

3/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	29.16
	9-Day RSI	35.04
	14-Day RSI	40.14
	3-1 Month Momentum %	17.48
	6-1 Month Momentum %	51.13
	12-1 Month Momentum %	99.7

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	3.06
	Quick Ratio	2.89
	Cash Ratio	1.77
	Days Inventory	36.22
	Days Sales Outstanding	82.33
	Days Payable	28.72

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	1.5
	Shareholder Yield %	2.98

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	60.14
	Operating Margin %	19.43
	Net Margin %	17.69
	EBITDA Margin %	30.28
	FCF Margin %	24.94
	OCF Margin %	26.53
	ROE %	23.33
	ROA %	12.09
	ROIC %	14.97
	3-Year ROIIC %	24.05
	ROC (Joel Greenblatt) %	118.17
	ROCE %	19.63
	Years of Profitability over Past 10-Year	8
	Moat Score	5
	Tariff Resilience Score	7

GF Value Rank

7/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	24.21
	Forward PE Ratio	18.33
	PE Ratio without NRI	18.49
	Shiller PE Ratio	45.54
	Price-to-Owner-Earnings	17.63
	PS Ratio	4.31
	PB Ratio	4.99
	Price-to-Tangible-Book	17.08
	Price-to-Free-Cash-Flow	17.27
	Price-to-Operating-Cash-Flow	16.23
	EV-to-EBIT	17.18
	EV-to-Forward-EBIT	21.61
	EV-to-EBITDA	13.95
	EV-to-Forward-EBITDA	13.44
	EV-to-Revenue	4.22
	EV-to-Forward-Revenue	4.15
	EV-to-FCF	16.95
	Price-to-GF-Value	1.09
	Price-to-Projected-FCF	1.4
	Price-to-Median-PS-Value	1.4
	Price-to-Graham-Number	3.74
	Earnings Yield (Greenblatt) %	5.82
	FCF Yield %	5.93
	Forward Rate of Return (Yacktman) %	-33.92

GF Value™: €78.45

FRA:0L8

Warning Signs

Warning! GuruFocus detected 2 Medium warning signs with 0L8. Try a 7-Day Free Trial to check it out.

Lantheus Holdings Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Lantheus Holdings Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-11-06 08:00	In 78 days
Third quarter earnings results for 2026	2026-11-06	In 77 days
Second quarter earnings results for 2026	2026-08-06	87.30 (+0.00%)
Goldman Sachs 47th Annual Global Healthcare Conference	2026-06-09 08:40	87.10 (+0.00%)
William Blair 46(th) Annual Growth Stock Conference	2026-06-03 12:10	82.70 (+0.00%)
First quarter earnings conference call for 2026	2026-05-07 08:00	72.90 (-0.41%)
First quarter earnings results for 2026	2026-05-07	72.90 (-0.41%)
General meeting for 2026	2026-04-30 09:00	71.30 (+0.00%)
Leerink Global Healthcare Conference	2026-03-10 08:00	62.30 (+0.00%)
TD Cowen 46th Annual Health Care Conferenc	2026-03-03 11:10	65.80 (+5.96%)

Show

Entries

Press Release

	Subject	Date
	Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?	2026-08-07
	Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH	2026-08-07
	$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)	2026-08-03
	Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?	2026-08-03
	Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders	2026-08-03
	LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders	2026-08-03
	Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH	2026-03-02
	Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH	2026-01-31
	LNTH FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit	2025-11-10
	Investors who lost money on Lantheus Holdings, Inc.(LNTH) should contact The Gross Law Firm about pending Class Action - LNTH	2025-11-10

10/Page

Articles on Lantheus Holdings Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.